Status:
COMPLETED
Develop Novel Phototherapy for Health Care of Patients With Sleep Disorder, Mild Cognitive Impairment, or Dementia
Lead Sponsor:
Kaohsiung Medical University
Conditions:
Dementia
Sleep Disorder
Eligibility:
All Genders
55-80 years
Phase:
NA
Brief Summary
Investigators aim to collaborate with the division of neurology, ophthalmology and dermatology at the Kaohsiung Medical University, and make a new phototherapy for participants suffering from dementia...
Detailed Description
Solar light is an important environmental factor for all living organisms. With the advancement of the lighting technology, artificial light, such as light emitting diode (LED), has become another maj...
Eligibility Criteria
Inclusion
- (1) The age is between 55 and 80 years old
- (2) Education level is above elementary school graduation
- (3) Use Edinburgh Inventory as the right hand
Exclusion
- (1) Neurological diseases, including cerebral stroke, epilepsy, Parkinson's disease and head trauma that cause local nerve signs
- (2) Mental illnesses, including mental disorders, drug addiction, abnormal personality, and poorly controlled schizophrenia;
- (3) Regularly take sedative and sleeping drugs or central nervous system stimulants
- (4) Major physical diseases, including cancer, poorly controlled diabetes, hypertension and thyroid disease, immune rheumatism, heart failure, chronic obstructive pulmonary disease, liver cirrhosis, and chronic kidney disease stages IV and V
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 7 2020
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04407351
Start Date
May 1 2017
End Date
May 7 2020
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan, 807